Full text is available at the source.
Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery
Using data analysis of sulfur and fluorine in medicines to find new drug design opportunities
AI simplified
Abstract
A total of 1969 drugs were analyzed to explore the role of sulfur and fluorine in pharmaceuticals over the past 50 years.
- Sulfur and fluorine are significant components in the composition of pharmaceuticals.
- Trends were examined across 12 disease categories using a graphical montage of drug information.
- The analysis highlights the structural diversity and evolution of sulfur in drug development.
- Fluorine has been increasingly integrated into pharmaceuticals during the last five decades.
- The findings aim to inspire new ideas in the field of drug development.
AI simplified